Ranibizumab

Overview

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Ranibizumab's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

0.5 mg0.5 (0.5)As recommended.intravitrealonce a month (approximately 28 days). Although less effective, treatment may be reduced to one injection every three months after the first four injections if monthly injections are not feasible. Compared to continued monthly dosing, dosing every 3 months will lead to an approximate 5-letter (1-line) loss of visual acuity benefit, on average, over the following 9 months. Patients should be evaluated regularly. Adequate anesthesia and a broad-spectrum microbicide should be given prior to the intravitreal injection.

Paedriatic Dosage (20kg)

No data regarding the Paedriatic dosage details of Ranibizumab is available.

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Ranibizumab is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Ranibizumab

Back to top

Manufacturers of Ranibizumab in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic